Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-005722
Filing Date
2012-02-03
Accepted
2012-02-03 16:05:11
Documents
1
Period of Report
2012-02-01

Document Format Files

Seq Description Document Type Size
1 RAAB ANNUAL GRANT rrd332262.html 4  
1 RAAB ANNUAL GRANT rrd332262.xml 4 3709
  Complete submission text file 0001181431-12-005722.txt   5169
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3290 WEST BAYSHORE RD PALO ALTO CA 94303
Business Address
RAAB G KIRK (Reporting) CIK: 0001210530 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 12569990